Jubilant Cadista Pharmaceuticals Inc.
NDC labeler code: 59746
What is a labeler?
The company whose name is on the package and in the FDA’s National Drug Code (NDC) Directory. It may make the medicine itself or sell medicine made by another company. The first part of every NDC code identifies the labeler.
Official FDA data only
Products, approvals and recalls come from the FDA (NDC Directory, Drugs@FDA, enforcement reports). Recalls are linked to this company by the NDC labeler code on the recalled product.
Questions about your medicine: ask your doctor or pharmacist. In an emergency, call 911.
Prescription medicines
- ValsartanDiovan · 4 products
- SildenafilViagra, Vybrique, Revatio · 4 products
- Terazosin hydrochlorideTezruly · 4 products
- Eslicarbazepine acetateAptiom · 4 products
- LamotrigineLamictal, Lamictal XR, Subvenite · 4 products
- Cyclobenzaprine hydrochlorideAmrix, Tonmya, Fexmid · 3 products
- Losartan potassium and hydrochlorothiazideHyzaar · 3 products
- IrbesartanAvapro · 3 products
- EscitalopramLexapro · 3 products
- Losartan potassiumLosortan Potassium, Cozaar, Arbli · 3 products
- TacrolimusPrograf, Astagraf XL, Envarsus XR · 3 products
- CarbamazepineTegretol XR, Carbatrol, Equetro · 3 products
- RoflumilastZoryve, Daliresp · 2 products
- ChlorthalidoneThalitone, Hemiclor · 2 products
- Nitrofurantoin (monohydrate/macrocrystals)Macrobid, Nitrofurantoin Mono, Nitrofurantoin Monohydrate Macrocrystalline · 2 products
- ProchlorperazineCompro · 2 products
- ValacyclovirValtrex · 2 products
- Methenamine hippurate1 product
FDA applications for these products
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
| Approved | Application | Medicine | Sponsor |
|---|---|---|---|
| August 4, 2025 | ANDA211219 | Eslicarbazepine acetate ESLICARBAZEPINE ACETATE | Jubilant Generics |
| March 6, 2025 | ANDA202954 | Sildenafil SILDENAFIL CITRATE | Jubilant Generics |
| December 20, 2024 | ANDA201156 | Sildenafil SILDENAFIL CITRATE | Jubilant Generics |
| December 1, 2023 | ANDA217675 | Methenamine hippurate METHENAMINE HIPPURATE | Jubilant Cadista |
| August 18, 2022 | ANDA216594 | Carbamazepine CARBAMAZEPINE | Umedica |
| February 18, 2022 | ANDA211013 | Nitrofurantoin (monohydrate/macrocrystals) NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) | Inventia |
| February 9, 2022 | ANDA211320 | Chlorthalidone CHLORTHALIDONE | Adaptis |
| October 3, 2018 | ANDA208236 | Roflumilast ROFLUMILAST | Pharmazone |
| February 23, 2015 | ANDA203534 | Irbesartan IRBESARTAN | Jubilant Generics |
| January 5, 2015 | ANDA203536 | Valsartan VALSARTAN | Jubilant Generics |
| September 28, 2012 | ANDA090802 | Tacrolimus TACROLIMUS | Panacea |
| September 18, 2012 | ANDA201170 | Losartan potassium LOSARTAN POTASSIUM | Jubilant Cadista |
| September 18, 2012 | ANDA201845 | Losartan potassium and hydrochlorothiazide LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Jubilant Cadista |
| September 12, 2012 | ANDA202280 | Escitalopram ESCITALOPRAM OXALATE | Jubilant Cadista |
| April 3, 2012 | ANDA201506 | Valacyclovir VALACYCLOVIR HYDROCHLORIDE | Jubilant Generics |
| January 27, 2009 | ANDA079132 | Lamotrigine LAMOTRIGINE | Jubilant Cadista |
| April 19, 2006 | ANDA077563 | Cyclobenzaprine hydrochloride CYCLOBENZAPRINE HYDROCHLORIDE | Jubilant Cadista |
| December 20, 2004 | ANDA075317 | Terazosin hydrochloride TERAZOSIN HYDROCHLORIDE | Jubilant Cadista |
| February 27, 1998 | ANDA040268 | Prochlorperazine PROCOMP | Jubilant Cadista |
The sponsor is the company that holds the FDA application; it can differ from the labeler.
Recall timeline
2022
-
December 27, 2022 · Class III · Terminated · D-0096-2023 · Prochlorperazine
Subpotent Drug: Out of specification for assay at the 18-month stability timepoint.
Prochlorperazine Maleate Tablets, USP 5mg, 100 tablets, RX Only, Jubilant Cadista Pharmaceuticals, Inc., Salisbury, Maryland 21801, NDC 59746-113-06
-
July 18, 2022 · Class II · Terminated · D-1293-2022 · Irbesartan
Failed dissolution specifications.
Irbesartan Tablets, USP, 150mg, 90- count bottles, Rx only, Manufactured by: Jubilant Generics Ltd. Roorkee- 247661, India, Marketed by: Jubilant Cadista Pharmaceuticals Inc. Salisbury, MD 21801, USA, NDC 59746-448-90
-
July 18, 2022 · Class II · Terminated · D-1294-2022 · Irbesartan
Failed Dissolution Specifications
Irbesartan Tablets, USP, 75 mg, 90- count bottle, Rx only, Manufactured by: Jubilant Generics Ltd. Roorkee- 247661, India, Marketed by: Jubilant Cadista Pharmaceuticals Inc. Salisbury, MD 21801, USA, NDC 59746-447-90
2021
-
March 15, 2021 · Class II · Terminated · D-0461-2021 · Valsartan
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Valsartan Tablets USP 40 mg 30 Scored Tablets Rx Only NDC 59746-360-30 Manufactured by: Jubilant Generics Ltd. Roorkee-247661, India
2020
-
May 26, 2020 · Class III · Terminated · D-1281-2020 · Lamotrigine
Presence of Foreign Substance visually consistent with the silica granules present in the desiccant packs utilized during storage of the product.
Lamotrigine Tablets, USP, 150 mg, 20,000-count bulk container, Manufactured by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801, USA, For repackaging by: AvKare Inc., Pulaski, TN 38478, Bulk Shipment, NDC 5974
2018
-
August 14, 2018 · Class III · Terminated · D-1104-2018 · Valsartan
Incorrect/Undeclared Excipient: There is a potential an incorrect grade of excipient was used during manufacturing.
Valsartan Tablets USP, 80 mg, 90-count bottle, Rx only, Manufactured by: Jubilant Generics Ltd Roorkee 0247661 India, Marketed by: Jubilant Cardista Pharmaceuticals Inc. Salisbury, MD 21801, USA, NDC 59746-361-90
-
August 14, 2018 · Class III · Terminated · D-1103-2018 · Valsartan
Incorrect/Undeclared Excipient: There is a potential an incorrect grade of excipient was used during manufacturing.
Valsartan Tablets USP, 40 mg, 30-count bottle, Rx only, Manufactured by: Jubilant Generics Ltd Roorkee 0247661 India, Marketed by: Jubilant Cardista Pharmaceuticals Inc. Salisbury, MD 21801, USA, NDC 59746-360-30
-
August 14, 2018 · Class III · Terminated · D-1105-2018 · Valsartan
Incorrect/Undeclared Excipient: There is a potential an incorrect grade of excipient was used during manufacturing.
Valsartan Tablets USP, 160 mg, 90-count bottle, Rx only, Manufactured by: Jubilant Generics Ltd Roorkee 0247661 India, Marketed by: Jubilant Cardista Pharmaceuticals Inc. Salisbury, MD 21801, USA, NDC 59746-362-90
2014
-
July 11, 2014 · Class II · Terminated · D-1500-2014 · Losartan potassium and hydrochlorothiazide
Presence of Foreign Substance: Tablets may contain dark blemishes identified as stainless steel.
Losartan Potassium and Hydrochlorothiazide Tablets, USP 100 mg/25 mg, 90-tablets per bottle, Rx Only, Manufactured by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801, NDC # 59746-339-90
What do the recall classes mean?
Class I: The most serious type: there is a reasonable chance that using the product will cause serious health problems or death.
Class II: Using the product may cause temporary or medically reversible health problems, or the chance of serious problems is remote.
Class III: Using the product is not likely to cause health problems (for example a labeling or packaging issue).
Next steps
- Find a pharmacy near youAsk which company made your medicine and whether it is recalled
- Latest FDA drug recallsAll companies, newest first
- All drug companiesA to Z
- All prescription drugs A to ZSearch by generic, brand or Spanish name
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 10, 2026, retrieved November 14, 2026